Latent Autoimmune Diabetes in Adults
"Latent Autoimmune Diabetes in Adults" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Autoimmune diabetes in adults with slowly progressive PANCREATIC BETA CELL failure and the presence of circulating autoantibodies to PANCREATIC ISLETS cell antigens.
| Descriptor ID |
D000071698
|
| MeSH Number(s) |
C18.452.394.750.714 C19.246.656 C20.111.576
|
| Concept/Terms |
Latent Autoimmune Diabetes in Adults- Latent Autoimmune Diabetes in Adults
- Diabetes Mellitus Type 1.5
- Type 1.5 Diabetes Mellitus
- Type 1.5 Diabetes
- Diabetes, Type 1.5
- LADA, Latent Autoimmune Diabetes in Adults
- Latent Autoimmune Diabetes of Adults
|
Below are MeSH descriptors whose meaning is more general than "Latent Autoimmune Diabetes in Adults".
Below are MeSH descriptors whose meaning is more specific than "Latent Autoimmune Diabetes in Adults".
This graph shows the total number of publications written about "Latent Autoimmune Diabetes in Adults" by people in this website by year, and whether "Latent Autoimmune Diabetes in Adults" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 2 | 0 | 2 |
| 2018 | 2 | 0 | 2 |
| 2019 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Latent Autoimmune Diabetes in Adults" by people in Profiles.
-
[LADA - a common serious disease that needs to be adressed]. Lakartidningen. 2019 Jun 18; 116.
-
Altered T-cell subsets and transcription factors in latent autoimmune diabetes in adults taking sitagliptin, a dipeptidyl peptidase-4 inhibitor: A 1-year open-label randomized controlled trial. J Diabetes Investig. 2019 Mar; 10(2):375-382.
-
Lower mortality and cardiovascular event rates in patients with Latent Autoimmune Diabetes In Adults (LADA) as compared with type 2 diabetes and insulin deficient diabetes: A cohort study of 4368 patients. Diabetes Res Clin Pract. 2018 May; 139:107-113.
-
A Rose by Any Other Name: Ketoacidosis Due to SGLT2 Inhibitors Reveals Latent Autoimmune Diabetes. Am J Med. 2018 Jan; 131(1):e1-e3.
-
Peripheral blood mononuclear cells of patients with latent autoimmune diabetes secrete higher levels of pro- & anti-inflammatory cytokines compared to those with type-1 diabetes mellitus following in vitro stimulation with ß-cell autoantigens. Indian J Med Res. 2017 Jun; 145(6):767-776.